Clinical Trial Update: EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety [Phase 2]

View source ↗

Summary

Phase 2 trial update on the safety of eplerenone in cyclosporine-treated kidney transplant recipients with chronic kidney insufficiency; current status is unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Transplantation

Drugs mentioned

• eplerenone (eplerenone)

Snippet

Sponsor: CHU de Reims | Conditions: Chronic Kidney Insufficiency, Kidney Transplantation | Phase 2 | Status: UNKNOWN